Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.

Saatci O, Kaymak A, Raza U, Ersan PG, Akbulut O, Banister CE, Sikirzhytski V, Tokat UM, Aykut G, Ansari SA, Dogan HT, Dogan M, Jandaghi P, Isik A, Gundogdu F, Kosemehmetoglu K, Dizdar O, Aksoy S, Akyol A, Uner A, Buckhaults PJ, Riazalhosseini Y, Sahin O. · 2020

Read Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. by Saatci O, Kaymak A, Raza U, Ersan PG, Akbulut O, Banister CE, Sikirzhytski V, Tokat UM, Aykut G, Ansari SA, Dogan HT, Dogan M, Jandaghi P, Isik A, Gundogdu F, Kosemehmetoglu K, Dizdar O, Aksoy S, Akyol A, Uner A, Buckhaults PJ, Riazalhosseini Y, Sahin O. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7229173.txt.

Description

Saatci and co-authors show that blocking an enzyme called LOX can restore chemotherapy's power against triple negative breast cancer. Their study appeared in Nature Communications. This is the most aggressive breast cancer subtype, and drug resistance is a major obstacle. The team grew resistant tumors in animals and read their gene activity. A hypoxia-driven tissue remodeler, LOX, stood out.

LOX stiffens the tissue around tumors by crosslinking collagen. Blocking it loosened that scaffold and let more drug penetrate. Key adhesion signals fell, and cancer cells resumed dying under treatment. Blocking the downstream signal gave the same benefit. Tests held in both flat cell cultures and 3D models. The authors propose LOX as a lever against resistance. Combining its blockade with standard chemotherapy is the suggested path.

Catalog record

CREATORSaatci O, Kaymak A, Raza U, Ersan PG, Akbulut O, Banister CE, Sikirzhytski V, Tokat UM, Aykut G, Ansari SA, Dogan HT, Dogan M, Jandaghi P, Isik A, Gundogdu F, Kosemehmetoglu K, Dizdar O, Aksoy S, Akyol A, Uner A, Buckhaults PJ, Riazalhosseini Y, Sahin O.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE78 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7229173

Browse the full library · About the Tower of Babel